Previous 10 | Next 10 |
Greenland Technologies Holding Corporation (GTEC) +186% on signing co-operation agreement with SOCMA.Immunome (IMNM) +152% on discovery of antibodies neutralizing SARS-CoV-2 variants.Avinger (AVGR) +57%.Heritage Global (HGBL) +42%.U.S. Well Services (USWS) +35%.Cleveland BioLabs (CB...
Cleveland BioLabs (CBLI) soars 27% after-hours after filing Form S-4 with the SEC in connection with its merger agreement with Cytocom, a biopharma creating next-generation immune therapies that deliver immune homeostasis. The Registration Statement is not yet in...
Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc. Combined public entity to develop and commercialize next-generation immune therapies that address unmet needs in oncology, infectious disease, inflammation and auto-immune-medi...
Gainers: Onconova Therapeutics (ONTX) +29%, Processa Pharmaceuticals (PCSA) +26%, AnPac Bio-Medical Science ANPC +25%, Oncolytics Biotech ONCY +22%, Cleveland BioLabs (CBLI) +15%.Losers: Interpace Biosciences IDXG -24%, AIkido Pharma AIKI...
ICON Public Limited (ICLR) has entered into an agreement with the privately held clinical-stage biotech company, Cytocom to manage the company’s Phase 3 clinical trial for its lead drug candidate, CYTO-201 in Crohn's disease."CYTO-201 is the program's lead clinical asset and we are ple...
Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021" PR Newswire WINTER PARK, Fla. , Dec. 22, 2020 /PRNewswire/ -- Cytocom, Inc. , a leading biopharmaceutical company creating second generation immune t...
EyeGate Pharmaceuticals (EYEG) +87% as it acquires Panoptes Pharma.NantKwest (NK) +32% as its partner, ImmunityBio, achieves primary endpoint in bladder cancer study.RealPage (RP) +31% as Thoma Bravo has agreed to buy the company for $9.6B.China Customer Relations Centers (CCRC...
NEW YORK, NY / ACCESSWIRE / December 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) concerning potential violations of the federal securities laws and/or breaches of f...
3 Penny Stocks To Watch Next Week While the end of 2020 can’t come soon enough, there’s still time left to find penny stocks to watch . Throughout 2020, several industries have seen massive growth due to the pandemic. With that, these industries have also promoted siza...
WeissLaw LLP Reminds MVC, TNAV, CBLI, and STND Shareholders About Its Ongoing Investigations NEW YORK , Dec. 2, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investiga...
News, Short Squeeze, Breakout and More Instantly...
Cleveland BioLabs Inc. Company Name:
CBLI Stock Symbol:
NASDAQ Market:
Cleveland BioLabs Inc. Website:
Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc." New Corporate Name and Updated Stock Ticker Symbol to Showcase Company's Post-Merger Transformation and Focus on Restoring Immune Health PR Newswire FORT COLLINS, Colo. , Aug. 31...
Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast Audio archive for the event may be accessed from the "Investors" section of the Cytocom website PR Newswire FORT COLLINS, Colo. , Aug. 16, 2021 /PRNewswire/ -- ...
Cytocom, Inc. Reports Second Quarter 2021 Financial Results -All-stock merger transaction between legacy Cleveland BioLabs and legacy Cytocom recently completed; Cytocom, Inc. common stock trading on Nasdaq as "CBLI"- -Well financed allowing multiple clinical programs that c...